Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the Q2FY23 & H1FY23 Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.htmI